Fulllength MSP1 is a major target of protective immunity after controlled human malaria infection
| dc.article.end-page | 16 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.26508/LSA.202301910 | en |
| dc.contributor.author | M Rosenkranz | en |
| dc.contributor.author | I Nkumama | en |
| dc.contributor.author | R Ogwang | en |
| dc.contributor.author | S Kraker | en |
| dc.contributor.author | E et al | en |
| dc.contributor.author | Kennedy Wambui | en |
| dc.date.accessioned | 2025-04-06T14:39:50Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.uri | https://hdl.handle.net/10539/44582 | |
| dc.journal.title | Fulllength MSP1 is a major target of protective immunity after controlled human malaria infection | en |
| dc.journal.volume | 7 | en |
| dc.title | Fulllength MSP1 is a major target of protective immunity after controlled human malaria infection | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 2.8 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client